Skip to main content

Find Clinical Trials

Home
Conditions
Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Clinical trial condition

Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Explore clinical trials studying Oligometastatic Non-small Cell Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Oligometastatic Non-small Cell Lung Cancer (NSCLC) trial results

Recruiting

First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.

NCT06840782

Conditions: Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Locations: Institut de Radiothérapie du Sud de l'Oise Creil, Hauts-de-France, France

Centre Sainte-Catherine Avignon, Provence-Alpes-Côte d'Azur Region, France

Gustave Roussy Villejuif, Île-de-France Region, France

View Trial Details

Completed

Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer

NCT02316002

Conditions: Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details